Skip to main content
    P

    PAVmed Inc (PAVM)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $1.63
    +0.29 (+21.73%)

    Market Cap: $13.03M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    PAVmed Inc (PAVM) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect PAVmed (PAVM) to earn -$2.33 per share in the fiscal year ending Dec 31, 2026, on revenue of $232500. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$2.38.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a larger loss and revenue estimates rise 158.1%.

    Fiscal year ending Dec 31, 2026
    -$2.33
    EPS consensus, revenue $232500
    Fiscal year ending Dec 31, 2027
    -$2.38
    EPS consensus, revenue $600000
    Next report
    Mar 29, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$2.33-$2.33 to -$2.331$232500$165000 to $3000002
    Dec 31, 2027-$2.38-$2.38 to -$2.381$600000$500000 to $7000002

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.57N/A4$132600$58800 to $2100004

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 2 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202610
    Fiscal year ending Dec 31, 202710

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$2.74.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$2.33-$2.62-$2.62-$2.62-$2.74N/A
    Fiscal year ending Dec 31, 2027-$2.38-$2.45-$2.45-$2.45-$2.74N/A

    Frequently Asked Questions About PAVM

    What is the PAVM stock forecast?

    Consensus analyst estimates put PAVmed's EPS at -$2.33 for the fiscal year ending Dec 31, 2026, on revenue of $232500.

    What EPS do analysts expect from PAVM next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$2.33, with estimates from -$2.33 to -$2.33 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$2.38, with estimates from -$2.38 to -$2.38 from 1 analyst.

    What revenue do analysts expect from PAVmed next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $232500, with estimates from $165000 to $300000. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $600000, with estimates from $500000 to $700000.

    How many analysts cover PAVM?

    1 analyst estimates EPS for PAVmed for the fiscal year ending Dec 31, 2026.